Literature DB >> 2181233

Isolation of the Actinobacillus pleuropneumoniae haemolysin gene and the activation and secretion of the prohaemolysin by the HlyC, HlyB and HlyD proteins of Escherichia coli.

D Gygi1, J Nicolet, J Frey, M Cross, V Koronakis, C Hughes.   

Abstract

The gene encoding the c. 105 kD secreted haemolysin protein of the porcine pathogen Actinobacillus pleuropneumoniae serotype 1 has been isolated by screening a lambda gt11 expression library in Escherichia coli with antiserum raised against the wild-type protein. A derivative recombinant DNA pJFF702 expressed the hlylA haemolysin gene from the pUC19 lac promoter but the resulting haemolysin I protein remained within the E. coli cell and was haemolytically inactive. Export of the intracellular A. pleuropneumoniae prohaemolysin out into the medium was achieved by the presence in trans of the E. coli haemolysin secretion genes hlyB and hlyD, and high levels of intracellular haemolytic activity were attained similarly by the E. coli post-translational haemolysin activator gene, hlyC. Southern hybridization of A. pleuropneumoniae parental DNA nevertheless indicated only a low degree of nucleotide sequence identity to the haemolysin structural and secretion genes hlyA and hlyB of E. coli. The data show that despite substantial nucleotide sequence divergence the A. pleuropneumoniae serotype 1 haemolysin determinant is closely related to that which is dispersed throughout other Gram-negative human and animal pathogens.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2181233     DOI: 10.1111/j.1365-2958.1990.tb02021.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  31 in total

1.  Association of the RTX proteins of Actinobacillus pleuropneumoniae with hemolytic, CAMP, and neutrophil-cytotoxic activities.

Authors:  J Devenish; J E Brown; S Rosendal
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

2.  Separable domains define target cell specificities of an RTX hemolysin from Actinobacillus pleuropneumoniae.

Authors:  D R McWhinney; Y F Chang; R Young; D K Struck
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

3.  Endobronchial inoculation with Apx toxins of Actinobacillus pleuropneumoniae leads to pleuropneumonia in pigs.

Authors:  E M Kamp; N Stockhofe-Zurwieden; L A van Leengoed; M A Smits
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  The Actinobacillus pleuropneumoniae hemolysin determinant: unlinked appCA and appBD loci flanked by pseudogenes.

Authors:  Y F Chang; R Young; D K Struck
Journal:  J Bacteriol       Date:  1991-08       Impact factor: 3.490

5.  Identification of RTX toxin target cell specificity domains by use of hybrid genes.

Authors:  C Forestier; R A Welch
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  Incomplete activation of Escherichia coli hemolysin (HlyA) due to mutations in the 3' region of hlyC.

Authors:  C Guzmán-Verri; F García; S Arvidson
Journal:  J Bacteriol       Date:  1997-09       Impact factor: 3.490

7.  Actinobacillus pleuropneumoniae hlyX gene homology with the fnr gene of Escherichia coli.

Authors:  J I MacInnes; J E Kim; C J Lian; G A Soltes
Journal:  J Bacteriol       Date:  1990-08       Impact factor: 3.490

8.  Acyltransferase-mediated selection of the length of the fatty acyl chain and of the acylation site governs activation of bacterial RTX toxins.

Authors:  Adriana Osickova; Humaira Khaliq; Jiri Masin; David Jurnecka; Anna Sukova; Radovan Fiser; Jana Holubova; Ondrej Stanek; Peter Sebo; Radim Osicka
Journal:  J Biol Chem       Date:  2020-05-27       Impact factor: 5.157

9.  Identification of a second hemolysin (HlyII) in Actinobacillus pleuropneumoniae serotype 1 and expression of the gene in Escherichia coli.

Authors:  J Frey; H van den Bosch; R Segers; J Nicolet
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

10.  Cytolysins of Actinobacillus pleuropneumoniae serotype 9.

Authors:  M A Smits; J Briaire; R Jansen; H E Smith; E M Kamp; A L Gielkens
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.